Permalink
Cannot retrieve contributors at this time
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
225 lines (215 sloc)
10.8 KB
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| <html> | |
| <head> | |
| <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> | |
| <title>ANRF Past Grant Awards</title> | |
| </head> | |
| <body bgcolor="#FFFFFF" bgproperties="fixed"> | |
| <div align="center"><center> | |
| <table border="0" cellspacing="0" width="640" style="margin-bottom: 0; padding-bottom: 0"> | |
| <tr> | |
| <td width="12%"><p align="right"><a href="index.htm"><img src="IMAGES/ANR_logo-sm.gif" | |
| alt="Back to Home" border="0" width="80" height="83"></a></td> | |
| <td width="88%"><font color="#400080"><font face="Bookman Old Style" size="5">A</font><font | |
| size="4" face="Bookman Old Style">RTHRITIS </font><font face="Bookman Old Style" size="5">N</font><font | |
| size="4" face="Bookman Old Style">ATIONAL </font><font face="Bookman Old Style" size="5">R</font><font | |
| size="4" face="Bookman Old Style">ESEARCH </font><font face="Bookman Old Style" size="5">F</font><font | |
| size="4" face="Bookman Old Style">OUNDATION</font></font></td> | |
| </tr> | |
| <tr> | |
| <td width="100%" colspan="2"><font size="4" face="Bookman Old Style" color="#400080">Press | |
| Logo To Return to Main Menu</font></td> | |
| </tr> | |
| </table> | |
| </center></div> | |
| <hr color="#FF0000" width="90%"> | |
| <div align="center"><center> | |
| <table border="0" cellpadding="2" cellspacing="0" width="600"> | |
| <tr> | |
| <td><font color="#FF0000"><big><b><u>Grant Awards Overview</u></b></big></font><p><strong><font | |
| size="3" color="#000000">The Arthritis National Research Foundation is proud to support | |
| young investigators studying the causes of arthritis. Their discoveries have led to the | |
| development of important new treatments to help those who spend each day in pain. The | |
| following table describes the grants awarded over the last five years.</font></strong></p> | |
| <p><strong><font size="3" color="#000000"> </font></strong></td> | |
| </tr> | |
| </table> | |
| </center></div><div align="center"><center> | |
| <table BORDER="1" CELLSPACING="1" CELLPADDING="7" WIDTH="600" bgcolor="#FFE6F4"> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><dir> | |
| <i><b><font FACE="Arial" SIZE="2"><p align="left"></font><font face="Arial" size="3" | |
| color="#400080">Date </font></b></i></p> | |
| </dir> | |
| </td> | |
| <td WIDTH="520" VALIGN="top"><dir> | |
| <i><b><font FACE="Arial" SIZE="2"><p></font><font face="Arial" size="3" color="#400080">Grants | |
| Awarded</font></b></i></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1998-99</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Elizabeth Mellins, M.D., Stanford University | |
| Medical Center: </i>$40,000 to study the genetics of rheumatoid arthritis.<b> </b>Dr. | |
| Mellins is examining if inherited genetic alterations in the recognition mechanism of the | |
| immune system are defective and cause RA patients to identify certain self-antigens as | |
| foreign.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1998-99</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Susan Kovats, Ph.D., Beckman Research Institute, | |
| City of Hope:</i> $35,000 to study the nature of self-antigens in rheumatoid<b> </b>arthritis.<b> | |
| </b>This study focuses on whether tissue damage or infection confuses the recognition | |
| mechanism of the immune system, causing attack on self-tissues.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1998-99</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Paul Utz, M.D., Harvard Medical School:</i> | |
| $40,000 to study cell death’s role in the development of autoimmune diseases.<b> </b>Dr. | |
| Utz is focusing<b> </b>on<b> </b>the mechanism of how proteins released from dying | |
| self-cells can be modified, then stimulate the patient’s immune system.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1998-99</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Rebecca Tuetken, M.D., Ph.D., University of Iowa: | |
| </i>$40,000 to study how the immune system recognizes and reacts against foreign and | |
| self-DNA. The study will provide insight to the innate immune response to bacterial DNA | |
| and the pathogenesis of SLE.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><strong><font face="Times New Roman" size="3"> </font></strong><p | |
| ALIGN="CENTER"><strong><font face="Times New Roman" size="3">1997-98</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Morteza Setareh, Ph.D., Scripps Research | |
| Institute</i>:<i> </i>$38,000 to study the molecular make-up of genes and the mechanism | |
| whereby an autoimmune response is triggered as in arthritis, lupus and other rheumatic | |
| diseases.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1997-98</strong></font></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Arunan Kaliyaperumal, Ph.D., Northwestern | |
| University</i>:<i> </i>$38,000 to study the etiologic mechanism of Systemic Lupus | |
| Erythematosus (Lupus) and design an autoantigen-specific therapy to block the autoimmune | |
| response in Lupus.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1997-98</strong></font></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Mariana Linker-Israeli, Ph.D., Cedars-Sinai | |
| Medical Center</i>: $38,000 for a project examining the cellular and molecular | |
| characteristics of patients with Lupus (SLE). By studying the susceptibility genes | |
| involved, Dr. Linker-Israeli hopes to devise screening methods and targeted regimens of | |
| therapy.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1994-95/</strong></font></p> | |
| <p ALIGN="CENTER"><font size="3"><strong>1996-97</strong></font></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Chaim Jacob, M.D., Ph.D., University of Southern | |
| California</i>: $50,000 for Systemic Lupus Erythematosus research utilizing new screening | |
| techniques to test Lupus genes for identifiable mutations, which could be targets for gene | |
| therapy in the future.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1996-97</strong></font></p> | |
| <p ALIGN="CENTER"><font size="3"><strong> </strong></font></p> | |
| <p ALIGN="CENTER"><font size="3"><strong> </strong></font></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Salvatore Albani, M.D., University of California, | |
| San Diego School of Medicine</i>: $50,000 to study abnormal immune responses specific to | |
| Pauciarticular Juvenile Rheumatoid Arthritis (pJRA). Provides new information about the | |
| cause of this disease and opens the possibility of prevention and new therapies.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><font size="3"><strong>1995-96</strong></font></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Onsi Kamel, M.D., Stanford University Medical | |
| Center</i>: $50,000 to study the propensity for patients with Rheumatoid Arthritis to | |
| develop lymphomas (cancer) as a result of immunosuppressive therapy used to treat the | |
| arthritis. Study to provide data to allow for more careful monitoring of such treatment, | |
| thereby preventing the development of such lymphomas.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1995-96</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">William Stohl, M.D., Ph.D., University of | |
| Southern California Medical Center</i>: $50,000 to assess the nature of the body’s | |
| inability to regulate antibody production in patients with Systemic Lupus Erythmatosus | |
| (SLE). With a better knowledge of these mechanisms, specific therapies may be developed to | |
| block autoantibody production and reduce (or eliminate) the manifestations of SLE.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1994-95</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Tetsuya Gatanaga, Ph.D., University of | |
| California, Irvine: </i>$37,500 to study<i> Cytokines</i>, a class of molecules, one of | |
| which is termed TNF, may be involved in the tissue destruction seen in Rheumatoid | |
| Arthritis. Dr. Gatanaga’s team has isolated a specific molecule that blocks <i>cytokine</i> | |
| activity.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| <tr> | |
| <td WIDTH="80" VALIGN="top"><p ALIGN="CENTER"><strong><font face="Times New Roman" | |
| size="3">1993-94</font></strong></td> | |
| <td WIDTH="520" VALIGN="top"><i><dir> | |
| <p><font face="Times New Roman" size="3">Betty Tsao, Ph.D., University of California, Los | |
| Angeles</i>: $42,000 to develop Immunotherapy by Peptides in Murine Lupus. A study to | |
| isolate and utilize peptides derived from autoantibodies to alter production of | |
| autoantibodies in patients with SLE.</font></p> | |
| </dir> | |
| </td> | |
| </tr> | |
| </table> | |
| </center></div> | |
| <p align="center"><a href="awards.htm"><font face="Times New Roman" size="3" | |
| color="#400080"><strong>Back to Top</strong></font></a></p> | |
| <hr color="#FF0000" width="90%"> | |
| <p align="center"><a href="about.htm">[Meet the ANRF]</a> <a href="whatis.htm">[Latest | |
| Research]</a> <a href="giving.htm">[Support the Research]</a> <a href="donors.htm">[Our | |
| Sponsors]</a><br> | |
| <a href="grant.htm">[Grant Application Guidelines</a> <a href="cureart1.htm">[<em>Cure</em>Arthritis | |
| Newsletter]</a> <a href="useful.htm">[Arthritis Info & Links]</a> <a | |
| href="contact.htm">[Contact Us]</a></p> | |
| <p align="center"><b><font color="#0000FF">This page, and all the contents of this Web | |
| site,<br> | |
| are Copyright © 1999 by TouchVision,<br> | |
| Seal Beach, California. All rights reserved.</font></b> <br> | |
| <font size="2" face="ARIAL,HELVETICA"><b>Best experienced with<br> | |
| <a href="http://www.microsoft.com/ie/ie.htm"><img src="ie_animated.gif" | |
| alt="Microsoft Internet Explorer" border="0" vspace="7" width="88" height="31"></a> </b></font></p> | |
| </body> | |
| </html> |